Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

doi:10.17816/kazmj71242

Kazan medical journal ›› 2021, Vol. 102 ›› Issue (3) : 409 -410. DOI: 10.17816/kazmj71242

Cochrane Review Summaries

abstract

Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

null. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Kazan medical journal, 2021, 102(3): 409-410 DOI:10.17816/kazmj71242